AARDVARK THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 15 Sept 2026)
What this means for you
Not registered yet, but its 16 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98857292
- Mark type
- Stylized text
- Filed
- 16 Nov 2024
- Published for opposition
- 29 Jul 2025
- Attorney of record
- Elise Wu
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research and development in the field of diagnosis and treatment of autism; providing medical and scientific research information in the field of autism; medical and scientific research, namely, conducting clinical trials for others for pharmaceuticals, drug development, and therapeutic applications in the field of autism; clinical research in the field of autism
Owner
- AARDVARK THERAPEUTICS, INC., San Diego, CA, US
- AARDVARK THERAPEUTICS, INC., San Diego, CA, US
Prosecution history
- 16 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Sept 2026 — CORRECTED NOA E-MAILED
- 15 Sept 2026 — SOU EXTENSION 1 GRANTED
- 29 Aug 2026 — SOU EXTENSION 1 FILED
- 23 Mar 2026 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 15 Sept 2026 — DIVISIONAL PROCESSING COMPLETE
- 23 Mar 2026 — DIVISIONAL REQUEST RECEIVED
- 29 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Aug 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 12 Aug 2026 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 03 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Jul 2026 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 22 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Mar 2026 — TEAS REQUEST TO DIVIDE RECEIVED